Cyclacel
Investors & Media

Corporate Presentations & Events

Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
04/15/18
4:35 PM EDT

Supporting Materials

Investors & Media